Anupam Rama
Stock Analyst at JP Morgan
(3.51)
# 915
Out of 5,002 analysts
273
Total ratings
45%
Success rate
6.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintains: Overweight | $27 → $37 | $25.44 | +45.44% | 2 | Sep 29, 2025 | |
| REPL Replimune Group | Downgrades: Underweight | n/a | $4.47 | - | 11 | Sep 19, 2025 | |
| CAMP Camp4 Therapeutics | Downgrades: Neutral | n/a | $3.07 | - | 1 | Sep 16, 2025 | |
| IDYA IDEAYA Biosciences | Maintains: Overweight | $72 → $74 | $27.12 | +172.86% | 10 | Sep 3, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Overweight | $55 → $70 | $52.56 | +33.18% | 10 | Sep 3, 2025 | |
| SLDB Solid Biosciences | Maintains: Overweight | $15 → $13 | $5.77 | +125.30% | 8 | Aug 14, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Overweight | $20 → $17 | $11.25 | +51.11% | 5 | Aug 14, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Overweight | $28 → $29 | $10.36 | +179.92% | 5 | Aug 14, 2025 | |
| KOD Kodiak Sciences | Upgrades: Neutral | $15 | $14.32 | +4.75% | 7 | Aug 14, 2025 | |
| VERA Vera Therapeutics | Maintains: Overweight | $56 → $53 | $28.84 | +83.80% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $14.53 | +106.47% | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $23.02 | +60.73% | 17 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $145 | $137.11 | +5.76% | 18 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 | $27.94 | -49.89% | 8 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $24 | $23.08 | +3.99% | 17 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $80 | $30.50 | +162.30% | 12 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $117 | $30.78 | +280.12% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $39 → $41 | $15.54 | +163.84% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $44 → $51 | $33.94 | +50.27% | 12 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $39 → $34 | $6.95 | +389.21% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $44 | $24.06 | +82.88% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $17 | $8.19 | +107.57% | 13 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $39 → $40 | $37.73 | +6.03% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $125 | $83.26 | +50.13% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.73 | - | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.50 | - | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $3.24 | - | 3 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $11 → $13 | $3.08 | +322.08% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $90 | $6.02 | +1,395.19% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 | $14.40 | +1,636.11% | 7 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.05 | - | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $58 | $55.43 | +4.64% | 1 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $7 → $12 | $14.14 | -15.10% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $29 → $37 | $5.53 | +569.08% | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $55 | $64.53 | -14.77% | 3 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $28 | $2.23 | +1,158.43% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $54 | $39.84 | +35.54% | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $45 | $0.66 | +6,744.11% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $27 | $12.52 | +115.65% | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $133 → $137 | $450.33 | -69.58% | 9 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $48 | $8.71 | +451.09% | 5 | Jul 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $10.09 | - | 2 | May 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $225 → $270 | $4.14 | +6,423.31% | 2 | Mar 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $1.38 | +2,073.91% | 1 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $62.08 | - | 2 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.48 | - | 2 | Jul 21, 2017 |
Maze Therapeutics
Sep 29, 2025
Maintains: Overweight
Price Target: $27 → $37
Current: $25.44
Upside: +45.44%
Replimune Group
Sep 19, 2025
Downgrades: Underweight
Price Target: n/a
Current: $4.47
Upside: -
Camp4 Therapeutics
Sep 16, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.07
Upside: -
IDEAYA Biosciences
Sep 3, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $27.12
Upside: +172.86%
BridgeBio Pharma
Sep 3, 2025
Maintains: Overweight
Price Target: $55 → $70
Current: $52.56
Upside: +33.18%
Solid Biosciences
Aug 14, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $5.77
Upside: +125.30%
ORIC Pharmaceuticals
Aug 14, 2025
Maintains: Overweight
Price Target: $20 → $17
Current: $11.25
Upside: +51.11%
Olema Pharmaceuticals
Aug 14, 2025
Maintains: Overweight
Price Target: $28 → $29
Current: $10.36
Upside: +179.92%
Kodiak Sciences
Aug 14, 2025
Upgrades: Neutral
Price Target: $15
Current: $14.32
Upside: +4.75%
Vera Therapeutics
Aug 7, 2025
Maintains: Overweight
Price Target: $56 → $53
Current: $28.84
Upside: +83.80%
Aug 7, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $14.53
Upside: +106.47%
Aug 4, 2025
Maintains: Overweight
Price Target: $35 → $37
Current: $23.02
Upside: +60.73%
Jul 31, 2025
Maintains: Neutral
Price Target: $140 → $145
Current: $137.11
Upside: +5.76%
Jul 30, 2025
Upgrades: Neutral
Price Target: $14
Current: $27.94
Upside: -49.89%
Jul 29, 2025
Upgrades: Neutral
Price Target: $24
Current: $23.08
Upside: +3.99%
Jul 24, 2025
Maintains: Overweight
Price Target: $42 → $80
Current: $30.50
Upside: +162.30%
Mar 27, 2025
Maintains: Overweight
Price Target: $104 → $117
Current: $30.78
Upside: +280.12%
Mar 20, 2025
Maintains: Overweight
Price Target: $39 → $41
Current: $15.54
Upside: +163.84%
Mar 13, 2025
Maintains: Overweight
Price Target: $44 → $51
Current: $33.94
Upside: +50.27%
Mar 5, 2025
Maintains: Overweight
Price Target: $39 → $34
Current: $6.95
Upside: +389.21%
Feb 26, 2025
Maintains: Overweight
Price Target: $42 → $44
Current: $24.06
Upside: +82.88%
Nov 12, 2024
Maintains: Overweight
Price Target: $16 → $17
Current: $8.19
Upside: +107.57%
Nov 5, 2024
Maintains: Overweight
Price Target: $39 → $40
Current: $37.73
Upside: +6.03%
Oct 4, 2024
Maintains: Overweight
Price Target: $100 → $125
Current: $83.26
Upside: +50.13%
Sep 30, 2024
Initiates: Neutral
Price Target: n/a
Current: $2.73
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.50
Upside: -
Apr 22, 2024
Upgrades: Neutral
Price Target: n/a
Current: $3.24
Upside: -
Apr 1, 2024
Maintains: Overweight
Price Target: $11 → $13
Current: $3.08
Upside: +322.08%
Aug 16, 2023
Maintains: Neutral
Price Target: $80 → $90
Current: $6.02
Upside: +1,395.19%
Jul 13, 2022
Downgrades: Neutral
Price Target: $250
Current: $14.40
Upside: +1,636.11%
Mar 8, 2022
Downgrades: Neutral
Price Target: n/a
Current: $8.05
Upside: -
Dec 10, 2021
Initiates: Overweight
Price Target: $58
Current: $55.43
Upside: +4.64%
Nov 5, 2021
Upgrades: Neutral
Price Target: $7 → $12
Current: $14.14
Upside: -15.10%
Oct 25, 2021
Upgrades: Neutral
Price Target: $29 → $37
Current: $5.53
Upside: +569.08%
Oct 12, 2021
Upgrades: Overweight
Price Target: $55
Current: $64.53
Upside: -14.77%
Aug 10, 2021
Initiates: Overweight
Price Target: $28
Current: $2.23
Upside: +1,158.43%
Mar 1, 2021
Downgrades: Neutral
Price Target: $54
Current: $39.84
Upside: +35.54%
Jan 11, 2021
Initiates: Overweight
Price Target: $45
Current: $0.66
Upside: +6,744.11%
Oct 12, 2020
Initiates: Overweight
Price Target: $27
Current: $12.52
Upside: +115.65%
May 7, 2020
Downgrades: Neutral
Price Target: $133 → $137
Current: $450.33
Upside: -69.58%
Jul 12, 2019
Downgrades: Neutral
Price Target: $29 → $48
Current: $8.71
Upside: +451.09%
May 10, 2018
Upgrades: Overweight
Price Target: n/a
Current: $10.09
Upside: -
Mar 6, 2018
Maintains: Overweight
Price Target: $225 → $270
Current: $4.14
Upside: +6,423.31%
Dec 4, 2017
Initiates: Overweight
Price Target: $30
Current: $1.38
Upside: +2,073.91%
Nov 16, 2017
Upgrades: Neutral
Price Target: n/a
Current: $62.08
Upside: -
Jul 21, 2017
Downgrades: Neutral
Price Target: n/a
Current: $1.48
Upside: -